Experimental Immunization against Lyme Borreliosis with Recombinant Osp Proteins: An Overview

Infection

Volumn 24, Issue 2, 1996, Pages 195-202

  Sadziene, A ^a,b   Barbour, A G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; INACTIVATED VACCINE; LIPOPROTEIN; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN; OUTER SURFACE PROTEIN A; RECOMBINANT VACCINE;

ACTIVE IMMUNIZATION; ANIMAL; AUTOIMMUNITY; BORRELIA BURGDORFERI; DOG; HAMSTER; HUMAN; IMMUNOLOGY; LYME DISEASE; MOUSE; PASSIVE IMMUNIZATION; RABBIT; REVIEW; TICK;

ANIMALS; ANTIGENS, SURFACE; AUTOIMMUNITY; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI GROUP; CRICETINAE; DOGS; HUMANS; IMMUNITY, ACTIVE; IMMUNIZATION, PASSIVE; LIPOPROTEINS; LYME DISEASE; MICE; RABBITS; TICKS; VACCINES, INACTIVATED; VACCINES, SYNTHETIC;

EID: 0030099703     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01713339     Document Type: Article

References (89)

1. Barbour, A. G., Fish, D.: The biological and social phenomenon of Lyme disease. Science 260 (1993) 1610-1616.
2. Sigal, L. H.: Experience with the first one hundred patients referred to a Lyme disease referral center. Am. J. Med. 88 (1990) 577-583.
3. Steere, A. C., Taylor, E., McHugh, G. L., Logigian, E. L.: Diagnosing Lyme disease. JAMA 269 (1993) 1812-1815.
4. Kalish, R. A., Leong, J. M., Steere, A. C.: Delay in the immune response to outer-surface proteins (Osp) A and B of B. burgdorferi: correlation with arthritis and treatment failure in susceptible patients with Lyme disease. Arthritis Rheum. 34 (1991) S43.
5. Halperin, J. J., Volkman, D. J., Wu, P.: Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41 (1991) 1571-1582.
6. Kruger, H., Heim, E., Schuknecht, B., Scholz, S.: Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases. J. Neurol. 238 (1991) 271-280.
7. Barthold, S. W., Beck, D. S., Hansen, G. M., Terwilliger, G. A., Moody, K. D.: Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162 (1990) 133-138.
8. Yang, L., Ma, Y., Schoenfeld, R., Griffiths, M., Eichwald, E., Araneo, B., Weis, J. J.: Evidence of B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect. Immun. 60 (1992) 3033-3041.
9. Schaible, U. E., Kramer, M. D., Wallich, R., Tran, T., Simon, M. M.: Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur. J. Immunol. 21 (1991) 2397-2405.
10. Alpert, B., Esin, J., Sivak, S. L., Wormser, G. P.: Incidence and prevalence of Lyme disease in a suburban Westchester County community. N. Y. State J. Med. 92 (1992) 5-8.
11. Steere, A. C., Green, J., Schoen, R. T., Taylor, E., Hutchinson, G. J., Rahn, D. W., Malawista, S. E.: Successful parenteral penicillin therapy of established Lyme arthritis. N. Engl. J. Med. 312 (1985) 869-874.
12. Steere, A. C., Dwyer, E., Winchester, R.: Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl. J. Med. 323 (1990) 219-223.
13. Szer, I. S., Taylor, E., Steere, A. C.: The long-term course of Lyme arthritis in children. N. Engl. J. Med. 325 (1991) 159-163.
14. Pachner, A. R., Duray, P., Steere, A. C.: Central nervous system manifestations of Lyme disease. Arch. Neurol. 46 (1989) 790-795.
15. Halperin, J. J., Kaplan, G. P., Brazinsky, S., Tsai, T. F., Ironside, A., Wu, P., Delfiner, J., Golightly, M., Brown, R. H.: Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch. Neurol. 47 (1990) 586-594.
16. Logigian, E. L., Kaplan, R. F., Steere, A. C.: Chronic neurologic manifestations of Lyme disease. N. Engl. J. Med. 323 (1990) 1438-1444.
17. Krupp, L. B., Masur, D., Schwartz, J., Coyle, P. K., Langenbach, L. J., Fernquist, S. K., Jandorf, L., Halperin, J. J.: Cognitive functioning in late Lyme borreliosis. Arch. Neurol. 48 (1991) 1125-1129.
18. Kaplan, R. F., Meadows, M. E., Vincent, L. C., Logigian, E. L., Steere, A. C.: Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients. Neurology 42 (1992) 1263-1267.
19. Edelman, R.: Perspective on the development of vaccines against Lyme disease. Vaccine 9 (1991) 531-532.
20. Johnson, R. C., Kodner, C., Russell, M.: Passive immunization of hamsters against experimental infection with Lyme disease spirochete. Infect. Immun. 53 (1986b) 713-714.
21. Johnson, R. C., Kodner, C., Russel, M.: Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect. Immun. 54 (1986a) 897-898.
22. Levy, S. A., Lissman, B. A., Ficke, C. M.: Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. J. Am. Vet. Med. Assoc. 202 (1993) 1834-1838.
23. Chu, H.-J., Chavez, L. G., Blumer, B. M., Sebring, R. W., Wasmoen, T. L., Acree, W. M.: Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin. J. Am. Vet. Med. Assoc. 201 (1992) 403-411.
24. Sadziene, A., Thompson, P. A., Barbour, A. G.: In vitro inhibition of Borrelia burgdorferi growth by antibodies. J. Infect. Dis. 167 (1993) 165-172.
25. Stover, C. K., Bansal, G. P., Hanson, M. S., Burlein, J. E., Palaszynski, S. R., Young, J. F., Koenig, S., Young, D. B., Sadziene, A., Barbour, A. G.: Protective immunity elicited by recombinant bacille Calmette-Guérin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J. Exp. Med. 178 (1993) 197-209.
26. Erdile, L. F., Brandt, M.-A., Warakomski, D. J., Westrack, G. J., Sadziene, A., Barbour, A. G., Mays, J. P.: The role of attached lipid in the immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61 (1993) 81-90.
27. Sadziene, A., Jonsson, M., Bergström, S., Bright, R. K., Kennedy, R. C., Barbour, A. G.: A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect. Immun. 62 (1994) 2037-2045.
28. Schaible, U. E., Kramer, M. D., Eichmann, K., Modolell, M., Museteanu, C., Simon, M. M.: Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc. Natl. Acad. Sci. USA. 87 (1990) 3768-3772.
29. Schaible, U. E., Wallich, R., Kramer, M. D., Gern, L., Anderson, J. F., Museteanu, C., Simon, M. M.: Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype. Vaccine 11 (1993) 1049-1054.
30. Barthold, S. W., Bockenstedt, L. K.: Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect. Immun. 61 (1993) 4696-4702.
31. Fikrig, E., Barthold, S. W., Kantor, F. S., Flavell, R. A.: Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250 (1990) 553.
32. Fikrig, E., Telford, S. R., Barthold, S. W., Kantor, F. S., Spielman, A., Flavell, R. A.: Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc. Natl. Acad. Sci. USA. 89 (1992c) 5418-5421.
33. Golde, W. T., Burkot, T. R., Piesman, J., Dolan, M. C., Capiau, C., Hauser, P., Dequesne, G., Lobet, Y.: The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. Vaccine 13 (1995) 435-441.
34. Telford, S. R. L., Fikrig, E., Barthold, S. W., Brunet, L. R., Spielman, A., Flavell, R. A.: Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. J. Exp. Med. 178 (1993) 755-758.
35. Simon, M. M., Schaible, U. E., Kramer, M. D., Eckerskorn, C., Museteanu, C., Muller-Hermelink, H., Wallich, R.: Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J. Infect. Dis. 164 (1991) 123-132.
36. Milch, L. J., Barbour, A. G.: Analysis of North American and European isolates of Borrelia burgdorferi with antiserum to a recombinant antigen. (Letter) J. Infect. Dis. 160 (1989) 351-353.
37. Lovrich, S. D., Callister, S. M., DuChateau, B. K., Lim, L. C. L., Winfrey, J., Day, S. P., Schell, R. F.: Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. Infect. Immun. 63 (1995) 2113-2119.
38. Langermann, S., Palaszynski, S., Sadziene, A., Stover, C. K., Koenig, S.: Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372 (1994) 552-555.
39. Fikrig, E., Barthold, S. W., Kantor, F. S., Flavell, R. A.: Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J. Infect. Dis. 164 (1991) 1224-1227.
40. Dunne, M., Al-Ramadi, B. K., Barthold, S. W., Flavell, R. A., Fikrig, E.: Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infect. Immun. 63 (1995) 1611-1614.
41. Fikrig, E., Barthold, A. W., Kantor, F. S., Flavell, R. A.: Long-term protection of mice from Lyme disease by vaccination with OspA. Infect. Immun. 60 (1992) 773-777.
42. Dunn, J. J., Lade, B. N., Barbour, A. G.: Outer surface protein (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level of expression and purification of a soluble recombinant form of OspA. Protein Expression Purif. 1 (1990) 159-168.
43. Fikrig, E., Barthold, S. W., Marcantonio, N., Deponte, K., Kantor, F. S., Flavell, R. A.: Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect. Immun. 60 (1992b) 657-661.
44. Keller, D., Koster, F. T., Marks, D. H., Hosbasch, P., Erdile, L. F., Mays, J. P.: Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. JAMA 271 (1994) 1764-1768.
45. Roehrig, J. T., Piesman, J., Hunt, A. R., Keen, M. G., Happ, C. M., Johnson, B. J. B.: The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. J. Immunol. 149 (1992) 3648-3653.
46. Gern, L., Schaible, U. E., Simon, M. M.: Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J. Infect. Dis. 167 (1993) 971-976.
47. Habicht, G. S.: Lyme disease: antigens of Borrelia burgdorferi and immune response to them. Ann. N. Y. Acad. Sci. 539 (1988) 112-118.
48. Craft, J. E., Fischer, D. K., Shimamoto, G. T., Steere, A. C.: Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G late in the illness. J. Clin. Invest. 78 (1986) 934-939.
49. Schaible, U. E., Gern, L., Wallich, R., Kramer, M. D., Prester, M., Simon, M. M.: Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen. Immunol. Lett. 36 (1993) 219-226.
50. Schwan, T. G., Piesman, J., Golde, W. T., Dolan, M. C., Rosa, P. A.: Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA. 92 (1995) 2909-2913.
51. Barbour, A. G., Tessier, S. L., Todd, W. J.: Lyme disease spirochetes and Ixodes tick spirochetes share a common surface antigen determinant defined by a monoclonal antibody. Infect. Immun. 41 (1983) 795-804.
52. Fung, B. P., McHugh, G. L., Leong, J. M., Steere, A. C.: Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the sero-diagnosis of early infection. Infect. Immun. 62 (1994) 3213-3221.
53. Padula, S. J., Sampieri, A., Dias, F., Szczepanski, A., Ryan, R. W.: Molecular characterization and expression of p23 (OspC) from a North American strain of Borrelia burgdorferi. Infect. Immun. 61 (1993) 5097-5105.
54. Burgdorfer, W., Hayes, S. F., Benach, J. L.: Development of Borrelia burgdorferi in ixodid tick vectors. Ann. N. Y. Acad. Sci. 539 (1988) 172-179.
55. Piesman, J.: Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J. Infect. Dis. 167 (1993) 1082-1085.
56. Piesman, J., Maupin, G. O., Campos, E. G., Happ, C. M.: Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method. J. Infect. Dis. 163 (1991) 895-897.
57. Piesman, J.: Transmission of Lyme disease spirochetes (Borrelia burgdorferi). Exp. Appl. Acarol. 7 (1989) 71-80.
58. Wallich, R., Helmes, C., Schaible, U. E., Lobet, Y., Moter, S. E., Kramer, M. D., Simon, M. M.: Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspPa, fla, HSP60 and HSP70 gene probes. Infect. Immun. 60 (1992) 4856-4866.
59. Wilske, B., Barbour, A. G., Bergström, S., Burman, N., Restrepo, B. I., Rosa, P. A., Schwan, T., Soutschek, E., Wallich, R.: Antigenic variation and strain heterogeneity in Borrelia spp. Res. Microbiol. 143 (1992) 583-596.
60. Wilske, B., Preac Mursic, V., Jauris, S., Pradel, I., Soutschek, E., Schwab, E., Wanner, G.: Immunological and molecular polymorphism of OspC: an immunodominant major outer surface protein of Borrelia burgdorferi. Infect. Immun. 61 (1993) 2182-2191.
61. Wilske, B., Preac Mursic, V., Göbel, U. B., Graf, B., Jauris, S., Soutschek, E.: An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J. Clin. Microbiol. 31 (1993) 340-350.
62. Wilske, B., Preac Mursic, V., Schierz, G., Kuhbeck, R., Barbour, A. G., Kramer, M.: Antigenic variability of Borrelia burgdorferi. Ann. N. Y. Acad. Sci. 539 (1988) 126-143.
63. Jonsson, M., Noppa, L., Barbour, A. G., Bergstrom, S.: Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of Osp operons of three isolates of different geographic origins. Infect. Immun. 60 (1992) 1845-1853.
64. Hughes, C. A., Engstrom, S. M., Coleman, L. A., Kodner, C. B., Johnson, R. C.: Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Infect. Immun. 61 (1993) 5115-5122.
65. Preac Mursic, V., Wilske, B., Patsouris, E., Jauris, S., Will, G., Soutschek, E., Rainhardt, S., Lehnert, G., Klockmann, U., Mehraein, P.: Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection. Infection 20 (1992) 342-350.
66. Bundoc, V. G., Barbour, A. G.: Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi. Infect. Immun. 57 (1989) 2733-2741.
67. Rosa, P. A., Schwan, T., Hogan, D.: Recombination between genes encoding major outer surface proteins A and B of Borrelia burgdorferi. Mol. Microbiol. 6 (1992) 3031-3040.
68. Sadziene, A., Rosa, P. A., Thompson, P. A., Hogan, D. M., Barbour, A. G.: Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J. Exp. Med. 176 (1992) 799-809.
69. Fikrig, E., Tao, H., Kantor, F. S., Barthold, S. W., Flavell, R. A.: Evasion of protective immunity by Borrelia burgdorferi by truncation of OspB. Proc. Natl. Acad. Sci. USA. 90 (1993) 4092-4097.
70. Fikrig, E., Tao, H., Barthold, S. W., Flavell, R. A.: Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B. Infect. Immun. 63 (1995) 1658-1662.
71. Carter, C. J., S., B., S. J., N., Barbour, A. G.: A family of surface-exposed proteins of 20 kilodaltons in the genus of Borrelia. Infect. Immun. 62 (1994) 2792-2799.
72. Lam, T. T., Nguyen, T.-P. K., Montgomery, R. R., Kantor, F. S., Fikrig, E., Flavell, R. A.: Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect. Immun. 62 (1994) 290-298.
73. Nguyen, T.-P. K., Lam, Y. T., Barthold, S. W., Telford III, S. R., Flavel, R. A., Fikrig, E.: Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF immunized mice. Infect. Immun. 62 (1994) 2079-2084.
74. Norris, S. J., Carter, C. J., Howell, J. K., Barbour, A. G.: Low passage-associated proteins of Borrelia burgdorferi: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect. Immun. 60 (1992) 4662-4672.
75. Katona, L. I., Beck, G., Habicht, G. S.: Purification and immunological characterization of a major low-molecular-weight lipoprotein from Borrelia burgdorferi. Infect. Immun. 60 (1992) 4995-5003.
76. Bunikis, J., Noppa, L., Bergström, S.: Molecular and phenotypic analysis of 66 kDa protein associated with the outer membrane of Lyme disease Borrelia, International Conference on Lyme borreliosis, Bologna, Italy, 1994, pp. P018M.
77. Sadziene, A., Thomas, D. D., Barbour, A. G.: Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization. Infect. Immun. 63 (1995) 1573-1580.
78. Probert, W. S., Allsup, K. M., LeFebre, R. B.: Identification and characterization of a surface-exposed 66-kilodalton protein from Borrelia burgdorferi. Infect. Immun. 63 (1995) 1933-1939.
79. Holt, S. C.: Anatomy and chemistry of spirochetes. Microbiol. Rev. 38 (1978) 114-160.
80. Callister, S. M., Schell, R. F., Lovrich, S. D.: Lyme disease assay which detects killed Borrelia burgdorferi. J. Clin. Microbiol. 29 (1991) 1773-1776.
81. Callister, S. M., Schell, R. F., Case, K. L., Steven, L. D., Day, S. P.: Characterization of borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J. Infect. Dis. 167 (1993) 158-164.
82. Pavia, C. S., Kissel, V., Bittker, S., Cabello, F., Levine, S.: Antiborrelial activity of serum from rats injected with the Lyme disease spirochete. J. Infect. Dis. 163 (1991) 656-659.
83. Johnson, R. C., Kodner, C. L., Russell, M.: Vaccination of hamsters against experimental infection with Borrelia burgdorferi. Zentralbl. Bakteriol. Microbiol. Hyg. Ser. A. 263 (1986) 45-48.
84. Zoschke, D. C., Skemp, A. A., Defosse, D. L.: Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease. Arch. Intern. Med. 114 (1991) 285-289.
85. Keane-Myers, A., Nickell, S. P.: T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 154 (1995) 1770-1776.
86. Kalish, R. A., Leong, J. M., Steere, A. C.: Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61 (1993) 2774-2779.
87. Sigal, L. H.: Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein. J. Infect. Dis. 167 (1993) 1372-1378.
88. Aberer, E., Brunner, C., Suchanek, G., Klade, H., Barbour, A., Stanek, G., Lassmann, H.: Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann. Neurol. 26 (1989) 732-737.
89. Mensi, N., Webb, D. R., Turck, C. W., Peltz, G. A.: Characterization of Borrelia burgdorferi proteins reactive with antibodies of a patient with Lyme arthritis. Infect. Immun. 58 (1990) 2404-2407.